Reduced and oxidized polysaccharides and methods of use thereof

US2018326073A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018326073-A1
Application numberUS-201615770937-A
CountryUS
Kind codeA1
Filing dateOct 26, 2016
Priority dateOct 26, 2015
Publication dateNov 15, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to reduced and highly oxidized polysaccharides, such as alginates, that are useful for encapsulating therapeutic or diagnostic agents, or lipid based nanoparticles, e.g., liposomes or virosomes, encapsulating therapeutic or diagnostic agents, prior to their delivery into a subject, as well as methods for making and using them.

First claim

Opening claim text (preview).

1 . A composition comprising a reduced polysaccharide, wherein said reduced polysaccharide comprises less than 2% of residual aldehydes; or said reduced polysaccharide comprises less than 3% of residual aldehydes; wherein said reduced polysaccharide is produced by reacting a polysaccharide with a diol specific oxidizing agent, thereby producing an oxidized polysaccharide comprising 0.1% or more oxidation on a molar basis; followed by reacting said oxidized polysaccharide with a water soluble aldehyde specific reducing agent to produce said reduced polysaccharide. 2 - 5 . (canceled) 6 . The composition of claim 1 , wherein said polysaccharide is selected from the group consisting of alginate, agarose, pullulan, scleroglucan, chitosan, elsinan, xanthan gum, dextran, mannose, gellan, levan, cellulose, hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, chondroitin sulfate E and β-d-glucans. 7 . (canceled) 8 . The composition of claim 1 , wherein said reduced polysaccharide comprises algoxinol having the following structure: 9 . The composition of claim 1 , wherein said aldehyde specific water soluble reducing agent is selected from the group consisting of sodium borohydride (NaBH 4 ); sodium cyanoborohydride (NaCNBH 3 ); hydrogen gas (H 2 ) in the presence of a catalyst; ammonia borane (H 3 NBH 3 ); and a borane complex. 10 . The composition of claim 9 , wherein said aldehyde specific water soluble reducing agent is ammonia borane and wherein said diol specific oxidizing agent is sodium periodate. 11 . (canceled) 12 . The composition of claim 1 , wherein said composition further comprises a cross-linking agent attached to the reduced polysaccharide. 13 . The composition of claim 12 , wherein said cross-linking agent is a click reagent. 14 . (canceled) 15 . A composition comprising a reduced polysaccharide and a cross-linking agent attached to the reduced polysaccharide. 16 . The composition of claim 15 , wherein said reduced polysaccharide is a reduced alginate polymer, wherein said reduced polysaccharide comprises algoxinol having the following structure: 17 . (canceled) 18 . The composition of claim 15 , wherein said reduced polysaccharide is produced by a method comprising the steps of: reacting the polysaccharide with a diol specific oxidizing agent to produce an aldehyde containing oxidized polysaccharide; and reacting said oxidized polysaccharide with a water soluble aldehyde specific reducing agent to produce said reduced polysaccharide. 19 . The composition of claim 18 , wherein said diol specific oxidizing agent is sodium periodate and wherein said water soluble aldehyde specific reducing agent is ammonia borane. 20 . (canceled) 21 . A composition comprising a highly oxidized polysaccharide and a cross-linking agent attached to the highly oxidized polysaccharide. 22 . The composition of claim 21 , wherein said highly oxidized polysaccharide is an alginate polymer, wherein said highly oxidized polysaccharide comprises algoxalate having the following structure: 23 . (canceled) 24 . The composition of claim 21 , wherein said highly oxidized polysaccharide is produced by a method comprising the steps of: reacting the polysaccharide with a diol specific oxidizing agent to produce an aldehyde containing oxidized polysaccharide; and reacting said oxidized polysaccharide with a second oxidizing agent which converts aldehydes into carboxylic acids to produce said highly oxidized polysaccharide. 25 . The composition of claim 24 , wherein said diol specific oxidizing agent is sodium periodate and wherein said second oxidizing agent is sodium chlorite. 26 . (canceled) 27 . The composition of claim 15 , wherein said cross-linking agent is a click reagent. 28 - 38 . (canceled) 39 . A hydrogel comprising a plurality of reduced and/or highly oxidized polysaccharides cross-linked to each other, wherein said hydrogel comprises a mesh size of 10 nm or less. 40 . The hydrogel of claim 39 , wherein said highly oxidized polysaccharides are highly oxidized alginate polymers produced by a method comprising the steps of: reacting an alginate with a diol specific oxidizing agent to produce an aldehyde containing oxidized alginate; and reacting said aldehyde containing oxidized alginate with a second oxidizing agent which converts aldehydes into carboxylic acids, thereby producing said highly oxidized alginate polymers. 41 . (canceled) 42 . The hydrogel of claim 40 , wherein said diol specific oxidizing agent is sodium periodate and wherein said second oxidizing agent is sodium chlorite. 43 - 44 . (canceled) 45 . The hydrogel of claim 39 , wherein said reduced polysaccharides are reduced alginate polymers produced by a method comprising the steps of: reacting an alginate with a diol specific oxidizing agent to produce an aldehyde containing oxidized alginate; and reacting said aldehyde containing oxidized alginate with a water soluble aldehyde specific reducing agent, thereby producing said reduced alginate polymers. 46 . (canceled) 47 . The hydrogel of claim 45 , wherein said diol specific oxidizing agent is sodium periodate and wherein said water soluble aldehyde specific reducing agent is ammonia borane. 48 - 49 . (canceled) 50 . The hydrogel of claim 39 , further comprising a therapeutic or diagnostic agent selected from the group consisting of a cell, a small molecule and a biologic. 51 - 59 . (canceled) 60 . The hydrogel of claim 39 , wherein said polysaccharides comprise a cross-linking agent attached to the polysaccharides and wherein said cross-linking agent is a click reagent. 61 - 62 . (canceled) 63 . An implantable or injectable device comprising the hydrogel of claim 39 . 64 . A method of producing a reduced polysaccharide, the method comprising the steps of: reacting a polysaccharide with a diol specific oxidizing agent to produce an aldehyde containing oxidized polysaccharide; and reacting said aldehyde containing oxidized polysaccharide with an aldehyde specific water soluble reducing agent, thereby producing said reduced polysaccharide. 65 - 73 . (canceled) 74 . A method of producing a highly oxidized polysaccharide covalently attached to a cross-linking agent, the method comprising the steps of: reacting a polysaccharide with a diol specific oxidizing agent to produce an aldehyde containing oxidized polysaccharide; reacting said aldehyde containing oxidized polysaccharide with a second oxidizing agent which converts aldehydes into carboxylic acids, thereby producing said highly oxidized polysaccharide; and reacting said highly oxidized polysaccharide with a cross-linking agent. 75 - 80 . (canceled) 81 . A drug delivery composition comprising a li

Assignees

Inventors

Classifications

  • for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Alginic acid; Derivatives thereof · CPC title

  • A61K47/36Primary

    Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title

  • Ophthalmic agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018326073A1 cover?
The present invention is directed to reduced and highly oxidized polysaccharides, such as alginates, that are useful for encapsulating therapeutic or diagnostic agents, or lipid based nanoparticles, e.g., liposomes or virosomes, encapsulating therapeutic or diagnostic agents, prior to their delivery into a subject, as well as methods for making and using them.
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification A61K47/36. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).